Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000760475 | SCV000890364 | pathogenic | not provided | 2018-10-12 | criteria provided, single submitter | clinical testing | The R583X nonsense variant in the SCN2A gene has been reported previously as a de novo change in an individual with autism (Codina-Solà et al., 2015). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R583X variant is not observed in large population cohorts (Lek et al., 2016). Therefore, this variant is classified as pathogenic. |
Labcorp Genetics |
RCV002533837 | SCV003524689 | pathogenic | Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11 | 2023-02-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg583*) in the SCN2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SCN2A are known to be pathogenic (PMID: 28379373). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of SCN2A-related conditions (PMID: 25969726, 33000761). ClinVar contains an entry for this variant (Variation ID: 620152). For these reasons, this variant has been classified as Pathogenic. |